{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:04:24Z","timestamp":1784113464390,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,15]]},"DOI":"10.7759\/cureus.112699","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T10:17:54Z","timestamp":1784110674000},"source":"Crossref","is-referenced-by-count":0,"title":["Predictors of Treatment Failure and Second-Line Therapy Outcomes After Rez\u016bm Therapy for Benign Prostatic Hyperplasia"],"prefix":"10.7759","author":[{"given":"Mohamed","family":"Alhabib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Engert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Soave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Wagenlehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Alghueiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Benign prostatic hyperplasia: an overview","volume":"7","author":"Roehrborn CG","year":"2005","unstructured":"Roehrborn CG. Benign prostatic hyperplasia: an overview. Rev Urol. 2005, 7:S3-S14.","journal-title":"Rev Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11884-010-0067-2","article-title":"Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors","volume":"5","author":"Parsons JK","year":"2010","unstructured":"Parsons JK. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep. 2010, 5:212-8. 10.1007\/s11884-010-0067-2","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"ref3","article-title":"BPH: epidemiology and comorbidities","volume":"12","author":"McVary KT","year":"2006","unstructured":"McVary KT. BPH: epidemiology and comorbidities. Am J Manag Care. 2006, 12:S122-8.","journal-title":"Am J Manag Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2008.01785.x","article-title":"Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management","volume":"62","author":"Emberton M","year":"2008","unstructured":"Emberton M, Cornel EB, Bassi PF, Fourcade RO, G\u00f3mez JM, Castro R. Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management. Int J Clin Pract. 2008, 62:1076-86. 10.1111\/j.1742-1241.2008.01785.x","journal-title":"Int J Clin Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell JD","year":"2003","unstructured":"McConnell JD, Roehrborn CG, Bautista OM, et al.. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003, 349:2387-98. 10.1056\/NEJMoa030656","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.03.058","article-title":"Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients","volume":"180","author":"Reich O","year":"2008","unstructured":"Reich O, Gratzke C, Bachmann A, et al.. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008, 180:246-9. 10.1016\/j.juro.2008.03.058","journal-title":"J Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.06.005","article-title":"Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement","volume":"58","author":"Ahyai SA","year":"2010","unstructured":"Ahyai SA, Gilling P, Kaplan SA, et al.. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010, 58:384-97. 10.1016\/j.eururo.2010.06.005","journal-title":"Eur Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/MDER.S135378","article-title":"Perspective on the Rez\u016bm(\u00ae) system: a minimally invasive treatment strategy for benign prostatic hyperplasia using convective radiofrequency water vapor thermal therapy","volume":"10","author":"Woo HH","year":"2017","unstructured":"Woo HH, Gonzalez RR. Perspective on the Rez\u016bm(\u00ae) system: a minimally invasive treatment strategy for benign prostatic hyperplasia using convective radiofrequency water vapor thermal therapy. Med Devices (Auckl). 2017, 10:71-80. 10.2147\/MDER.S135378","journal-title":"Med Devices (Auckl)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013251.pub2","article-title":"Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia","volume":"3","author":"Kang TW","year":"2020","unstructured":"Kang TW, Jung JH, Hwang EC, Borofsky M, Kim MH, Dahm P. Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia. Cochrane Database Syst Rev. 2020, 3:CD013251. 10.1002\/14651858.CD013251.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2018.02.3088","article-title":"Three-year treatment outcomes of water vapor thermal therapy compared to doxazosin, finasteride and combination drug therapy for men with benign prostatic hyperplasia: cohort data from the MTOPS trial","volume":"200","author":"Gupta N","year":"2018","unstructured":"Gupta N, Rogers T, Holland B, Helo S, Dynda D, McVary KT. Three-year treatment outcomes of water vapor thermal therapy compared to doxazosin, finasteride and combination drug therapy for men with benign prostatic hyperplasia: cohort data from the MTOPS trial. J Urol. 2018, 200:405-13. 10.1016\/j.juro.2018.02.3088","journal-title":"J Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001778","article-title":"Final 5-year outcomes of the multicenter randomized sham-controlled trial of Rez\u016bm water vapor thermal therapy for treatment of moderate-to-severe lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"206","author":"McVary KT","year":"2021","unstructured":"McVary KT, Gittelman MC, Goldberg KA, et al.. Final 5-year outcomes of the multicenter randomized sham-controlled trial of Rez\u016bm water vapor thermal therapy for treatment of moderate-to-severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2021, 206:715-24. 10.1097\/JU.0000000000001778","journal-title":"J Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021365","article-title":"Water vapor thermal therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: systematic review and meta-analysis","volume":"99","author":"Miller LE","year":"2020","unstructured":"Miller LE, Chughtai B, McVary K, Gonzalez RR, Rojanasarot S, DeRouen K, Bhattacharyya S. Water vapor thermal therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: systematic review and meta-analysis. Medicine (Baltimore). 2020, 99:e21365. 10.1097\/MD.0000000000021365","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00836-w","article-title":"Real-world experience of water vapour therapy (Rezum) in patients with benign prostatic enlargement: a retrospective single-center study","volume":"28","author":"Wolters M","year":"2025","unstructured":"Wolters M, Krastel M, Winkler T, et al.. Real-world experience of water vapour therapy (Rezum) in patients with benign prostatic enlargement: a retrospective single-center study. Prostate Cancer Prostatic Dis. 2025, 28:160-6. 10.1038\/s41391-024-00836-w","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia","volume":"148","author":"Barry MJ","year":"1992","unstructured":"Barry MJ, Fowler FJ Jr, O\u2019Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett ATK. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992, 148:1549-57. 10.1016\/S0022-5347(17)36966-5","journal-title":"J Urol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo D","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004, 240:205-13. 10.1097\/01.sla.0000133083.54934.ae","journal-title":"Ann Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/15330338231155000","article-title":"Minimally invasive treatment in benign prostatic hyperplasia (BPH)","volume":"22","author":"Sciacqua LV","year":"2023","unstructured":"Sciacqua LV, Vanzulli A, Di Meo R, Pellegrino G, Lavorato R, Vitale G, Carrafiello G. Minimally invasive treatment in benign prostatic hyperplasia (BPH). Technol Cancer Res Treat. 2023, 22:55000. 10.1177\/15330338231155000","journal-title":"Technol Cancer Res Treat"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1756287218793084","article-title":"Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia","volume":"10","author":"Westwood J","year":"2018","unstructured":"Westwood J, Geraghty R, Jones P, Rai BP, Somani BK. Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia. Ther Adv Urol. 2018, 10:327-33. 10.1177\/1756287218793084","journal-title":"Ther Adv Urol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251721","article-title":"Cluster analysis of men undergoing surgery for BPH\/LUTS reveals prominent roles of both bladder outlet obstruction and diminished bladder contractility","volume":"16","author":"Schneider AJ","year":"2021","unstructured":"Schneider AJ, Grimes M, Lyon W, Kemper A, Wang S, Bushman W. Cluster analysis of men undergoing surgery for BPH\/LUTS reveals prominent roles of both bladder outlet obstruction and diminished bladder contractility. PLoS One. 2021, 16:e0251721. 10.1371\/journal.pone.0251721","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5213\/inj.2346252.126","article-title":"Surgical outcomes and predictive factors in patients with detrusor underactivity undergoing bladder outlet obstruction surgery","volume":"28","author":"Chuang MS","year":"2024","unstructured":"Chuang MS, Ou YC, Cheng YS, Wu KY, Wang CT, Huang YC, Kao YL. Surgical outcomes and predictive factors in patients with detrusor underactivity undergoing bladder outlet obstruction surgery. Int Neurourol J. 2024, 28:59-66. 10.5213\/inj.2346252.126","journal-title":"Int Neurourol J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2018.12.041","article-title":"Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study","volume":"126","author":"McVary KT","year":"2019","unstructured":"McVary KT, Rogers T, Roehrborn CG. Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology. 2019, 126:171-9. 10.1016\/j.urology.2018.12.041","journal-title":"Urology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5173\/ceju.2024.0224","article-title":"Outcomes of Rezum water vapor therapy for benign prostate obstruction with 1-year follow-up: largest real-world data from Turkey","volume":"78","author":"Cakiroglu B","year":"2025","unstructured":"Cakiroglu B, Acar \u0130C, Uyan\u0131k BS. Outcomes of Rezum water vapor therapy for benign prostate obstruction with 1-year follow-up: largest real-world data from Turkey. Cent European J Urol. 2025, 78:144-50. 10.5173\/ceju.2024.0224","journal-title":"Cent European J Urol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4111\/kju.2013.54.12.840","article-title":"Effect of transurethral resection of the prostate based on the degree of obstruction seen in urodynamic study","volume":"54","author":"Min DS","year":"2013","unstructured":"Min DS, Cho HJ, Kang JY, Yoo TK, Cho JM. Effect of transurethral resection of the prostate based on the degree of obstruction seen in urodynamic study. Korean J Urol. 2013, 54:840-5. 10.4111\/kju.2013.54.12.840","journal-title":"Korean J Urol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4081\/aiua.2022.2.174","article-title":"Is holmium laser enucleation of prostate equally effective in management of benign prostatic hyperplasia patients with either voiding or storage lower urinary tract symptoms? A comparative study","volume":"94","author":"Mostafa MM","year":"2022","unstructured":"Mostafa MM, Patil N, Khalil M, Elgammal MA, Mahdy A. Is holmium laser enucleation of prostate equally effective in management of benign prostatic hyperplasia patients with either voiding or storage lower urinary tract symptoms? A comparative study. Arch Ital Urol Androl. 2022, 94:174-9. 10.4081\/aiua.2022.2.174","journal-title":"Arch Ital Urol Androl"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1159\/000547152","article-title":"Predictors of treatment failure, second-line therapy outcomes, and patient satisfaction after prostatic artery embolization: a retrospective study in benign prostatic hyperplasia","volume":"110","author":"Alghueiri K","year":"2026","unstructured":"Alghueiri K, Engert PC, Alhabib M, Schott P, Arafat W, Soave A, Friedrich MG. Predictors of treatment failure, second-line therapy outcomes, and patient satisfaction after prostatic artery embolization: a retrospective study in benign prostatic hyperplasia. Urol Int. 2026, 110:125-33. 10.1159\/000547152","journal-title":"Urol Int"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-5538.IBJU.2021.0653","article-title":"Prevalence and risk factors of incidental prostate cancer in certain surgeries for benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"48","author":"Guo Z","year":"2022","unstructured":"Guo Z, He J, Huang L, et al.. Prevalence and risk factors of incidental prostate cancer in certain surgeries for benign prostatic hyperplasia: a systematic review and meta-analysis. Int Braz J Urol. 2022, 48:915-29. 10.1590\/S1677-5538.IBJU.2021.0653","journal-title":"Int Braz J Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/510466-predictors-of-treatment-failure-and-second-line-therapy-outcomes-after-rezm-therapy-for-benign-prostatic-hyperplasia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T10:17:55Z","timestamp":1784110675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/510466-predictors-of-treatment-failure-and-second-line-therapy-outcomes-after-rezm-therapy-for-benign-prostatic-hyperplasia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.112699","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,15]]}}}